Fairfield, Bush & Co’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-200
Closed -$1.13K 165
2023
Q4
$1.13K Buy
+200
New +$1.13K ﹤0.01% 429